NHI Announces Fourth Quarter 2025 Results

About this update from National Health Investors, Inc.

[{"type":"text","content":"MURFREESBORO, TN / ACCESS Newswire / February 26, 2026 / National Health Investors, Inc. (NYSE:NHI) announced today its results for the fourth quarter and year ended December 31, 2025.","length":184,"tagName":"p"},{"type":"text","content":"CEO Comments","length":12,"tagName":"p"},{"type":"text","content":""NHI generated strong financial results in 2025 that exceeded our initial NAREIT FFO, Normalized FFO and FAD guidance," said Eric Mendelsohn, NHI's President and CEO.","length":180,"tagName":"p"},{"type":"text","content":""We significantly expanded the Senior Housing Operating Portfolio ("SHOP") during 2025 from 15 properties to 26 properties. We recently announced the addition of another nine properties for $105.5 million, which is our largest SHOP acquisition ever and increases our total SHOP investments to approximately $740.0 million. We continue to make strategic hires driven by the excellent organic NOI growth opportunity within the SHOP platform.","length":454,"tagName":"p"},{"type":"text","content":""We announced investments of $392.3 million in 2025 which was our most active year since 2016 and we are confident that the pipeline supports exceptional external growth for the foreseeable future. Our leverage is below 4.0 times net debt to Adjusted EBITDA positioning NHI favorably to capitalize on these opportunities. We exceeded the midpoint of our original 2025 Normalized FFO per share guidance by nearly 6% and are excited about the growth prospects in 2026," concluded Mr. Mendelsohn.","length":503,"tagName":"p"},{"type":"text","content":"Financial Results and Recent Events","length":35,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Net income attributable to common stockholders per diluted share for the fourth quarter ended December 31, 2025 was $0.80 per share compared to $0.95 per share during the same period in the prior year. Net income attributable to common stockholders per diluted share for the year ended December 31, 2025 was $3.02 per share compared to $3.13 per share during the same period in the prior year. Net income attributable to common stockholders for the year ended December 31, 2025 included $1.6 million of proxy contest and related expenses for a proxy campaign associated with the Company's 2025 annual meeting of stockholders and $1....

More updates from National Health Investors, Inc.